Abrika Pharmaceuticals Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $110M
Latest Deal Amount

Abrika Pharmaceuticals General Information

Description

Developer of drug delivery technologies. The company manufactures generic pharmaceutical products and proprietary drugs for tablets and capsules. The company's products include pellets, microparticles, coated granules, transmucosal and transdermal delivery.

Contact Information

Website
www.abrika.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Other Healthcare Technology Systems
Drug Discovery
Acquirer
Primary Office
  • 13800 North West 2nd Avenue
  • Suite 190
  • Sunrise, FL 33325
  • United States
+1 (954) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Abrika Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 23-Apr-2007 $110M 00000 Completed
1. Early Stage VC Completed
To view Abrika Pharmaceuticals’s complete valuation and funding history, request access »

Abrika Pharmaceuticals Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Signet Healthcare Partners Growth/Expansion Minority 000 0000 000000 0
To view Abrika Pharmaceuticals’s complete investors history, request access »